WORK to Save Lives Act

Summary#

This bill directs the Secretary of Labor, through OSHA, to address opioid overdose reversal medication in workplaces. Within 270 days after enactment, OSHA must issue non‑mandatory guidance to employers on getting and keeping overdose reversal medication and on offering voluntary annual employee training. The bill also requires OSHA to issue regulations, within the same 270 days, that make those same steps mandatory for each Federal agency. The bill defines "employer" by reference to the Occupational Safety and Health Act but excludes the United States Postal Service. It also says "Federal agency" includes the Veterans Health Administration.

What it means for you#

• Private employers: OSHA will publish non‑mandatory guidance about acquiring and maintaining overdose reversal medication and about offering voluntary annual training to employees.
• Federal employees and agencies: Federal agencies must acquire and maintain overdose reversal medication and offer voluntary annual employee training every year under OSHA regulations.
• Employees: Training would be voluntary and offered on an annual basis; the bill does not change whether you must attend.

Expenses#

No publicly available information.

Proponents' View#

The sponsors set out requirements for OSHA to provide guidance for employers and to require Federal agencies to have overdose reversal medication available and to offer yearly voluntary training to employees.

Opponents' View#

No publicly available information.